Similar articles

• Molecular diagnostic techniques for the clinical evaluation of gliomas.

  Kelley TW, Tubbs RR, Prayson RA. Kelley TW, et al. Diagn Mol Pathol. 2005 Mar;14(1):1-8. doi: 10.1097/01.pdm.0000138207.96718.85. Diagn Mol Pathol. 2005. PMID: 15714057 Review.
• Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.

  Fujisawa H, Kurrer M, Reis RM, Yonekawa Y, Kleihues P, Ohgaki H. Fujisawa H, et al. Am J Pathol. 1999 Aug;155(2):387-94. doi: 10.1016/S0002-9440(10)65135-8. Am J Pathol. 1999. PMID: 10433932 Free PMC article.
• Functional evaluation of p53 and PTEN gene mutations in gliomas.

  Kato H, Kato S, Kumabe T, Sonoda Y, Yoshimoto T, Kato S, Han SY, Suzuki T, Shibata H, Kanamaru R, Ishioka C. Kato H, et al. Clin Cancer Res. 2000 Oct;6(10):3937-43. Clin Cancer Res. 2000. PMID: 11051241
• Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.

  Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD. Bigner SH, et al. Am J Pathol. 1999 Aug;155(2):375-86. doi: 10.1016/S0002-9440(10)65134-6. Am J Pathol. 1999. PMID: 10433931 Free PMC article.
• [Molecular biology of brain tumors].

  Tamiya T, Morisaki K, Miyake K, Matsumoto Y, Nagao S, Daido S, Ichikawa T. Tamiya T, et al. Nihon Rinsho. 2005 Sep;63 Suppl 9:30-4. Nihon Rinsho. 2005. PMID: 16201496 Review. Japanese. No abstract available.